Name: UMIN ID:
| Unique ID issued by UMIN | UMIN000044090 |
|---|---|
| Receipt number | R000050350 |
| Scientific Title | Adverse events frequency caused by nivolumab and ipilimumab combination therapy: meta-analysis |
| Date of disclosure of the study information | 2021/05/01 |
| Last modified on | 2022/04/29 11:06:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2021/05/01 14:01:50 | ||
| 2 | Update | 2021/05/01 16:57:32 | Other related information |
|
| 3 | Update | 2022/04/29 10:58:07 | Tel1 |
|
| 4 | Update | 2022/04/29 11:01:12 | Recruitment status Date of IRB Other related information |
|
| 5 | Update | 2022/04/29 11:06:13 | Number of participants that the trial has enrolled Results |
|
| 6 | Update | 2022/04/29 11:06:50 | Tel |